Expression Pattern of Immune Suppressive Cytokines and Growth Factors in Oesophageal Adenocarcinoma Reveal a Tumour Immune Escape-promoting Microenvironment

被引:24
作者
Milano, F. [1 ]
Jorritsma, T. [2 ,3 ]
Rygiel, A. M. [1 ]
Bergman, J. J. [4 ]
Sondermeijer, C. [4 ]
Ten Brinke, A. [2 ,3 ]
Vanham, S. M. [2 ,3 ]
Krishnadath, K. K. [4 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Lab Expt Internal Med, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Sanquin Res CLB, Dept Immunopathol, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands
[4] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1105 AZ Amsterdam, Netherlands
关键词
D O I
10.1111/j.1365-3083.2008.02183.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Immunotherapy for solid cancers, such as oesophageal adenocarcinoma (OAC), is generally hampered by an unfavourable immunological tumour microenvironment. This prompted us to investigate the nature of the OAC environment. Biopsies of tumour and normal control tissues were collected from 17 OAC patients, and investigated using fluorescent immunohistochemistry (IHC) for the expression of cyclooxygenase-2 (COX-2), vascular endothelial growth factor (VEGF), transforming growth factor-beta, indoleamine 2-3 dioxygenase, CXCL3 and CXCR1, and for measuring a panel of cytokines by cytometric bead array (CBA), and for Granzyme B (GrB), Perforin and PI9 detection by semi-quantitative PCR (QPCR). IHC showed that expression of all the above-mentioned factors is upregulated in 80-93% of the tumours. By QPCR, the cytokine interleukin (IL)-8 was significantly upregulated in tumour samples (P < 0.05). IL-6, IL-10, GrB and Perforin did not show any significant difference between normal and tumour samples, whereas PI9 levels were significantly higher in normal when compared with the tumour samples. CBA confirmed upregulation of IL-8 and show upregulation of IL-1 beta in the tumours (P < 0.05). Regarding IL-6 and interferon (IFN)-gamma, no significant differences were observed between normal and tumour tissues. The OAC microenvironment is characterized by a lack of cytokines and factors that normally would enhance anti-cancer responses, such as IFN-gamma and GrB, and by a high expression of several immuno-suppressive factors, such as COX-2, VEGF and IL-8. For future improvement of treatment efficacy of OAC patients, it will be of importance to combine immunotherapy with immune-modulating agents.
引用
收藏
页码:616 / 623
页数:8
相关论文
共 38 条
  • [1] Prognostic factors and COX-2 expression in advanced stage esophageal squamous cell carcinoma
    Alici, Suleyman
    Ugras, Serdar
    Bayram, Irfan
    Izmirli, Mustafa
    [J]. ADVANCES IN THERAPY, 2006, 23 (05) : 672 - 679
  • [2] Inflammation and cancer: back to Virchow?
    Balkwill, F
    Mantovani, A
    [J]. LANCET, 2001, 357 (9255) : 539 - 545
  • [3] Membrane-associated TGF-β1 inhibits human memory T cell signaling in malignant and nonmalignant inflammatory microenvironments
    Broderick, Lori
    Bankert, Richard B.
    [J]. JOURNAL OF IMMUNOLOGY, 2006, 177 (05) : 3082 - 3088
  • [4] High TGFβ-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene
    Bruna, Alejandra
    Darken, Rachel S.
    Rojo, Federico
    Ocana, Alberto
    Penuelas, Silvia
    Arias, Alexandra
    Paris, Raquel
    Tortosa, Avelina
    Mora, Jaume
    Baselga, Jose
    Seoane, Joan
    [J]. CANCER CELL, 2007, 11 (02) : 147 - 160
  • [5] Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry, allergies vs. non-allergies
    Cook, EB
    Stahl, JL
    Lowe, L
    Chen, R
    Morgan, E
    Wilson, J
    Varro, R
    Chan, A
    Graziano, FM
    Barney, NP
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 2001, 254 (1-2) : 109 - 118
  • [6] Elevated tumour interleukin-1β is associated with systemic inflammation:: a marker of reduced survival in gastro-oesophageal cancer
    Deans, D. A. C.
    Wigmore, S. J.
    Gilmour, H.
    Paterson-Brown, S.
    Ross, J. A.
    Fearon, K. C. H.
    [J]. BRITISH JOURNAL OF CANCER, 2006, 95 (11) : 1568 - 1575
  • [7] Activation of the interleukin-6/STAT 3 antiapoptotic pathway in esophageal cells by bile acids and low pH: Relevance to Barrett's esophagus
    Dvorak, Katerina
    Chavarria, Melissa
    Payne, Claire M.
    Ramsey, Lois
    Crowley-Weber, Cara
    Dvorakova, Barbora
    Dvorak, Bohuslav
    Bernstein, Harris
    Holubec, Hana
    Sampliner, Richard E.
    Bernstein, Carol
    Prasad, Anil
    Green, Sylvan B.
    Garewal, Harinder
    [J]. CLINICAL CANCER RESEARCH, 2007, 13 (18) : 5305 - 5313
  • [8] Increased expression and secretion of interleukin-6 in patients with Barrett's esophagus
    Dvorakova, K
    Payne, CM
    Ramsey, L
    Holubec, H
    Sampliner, R
    Dominguez, J
    Dvorak, B
    Bernstein, H
    Bernstein, C
    Prasad, A
    Fass, R
    Cui, HY
    Garewal, H
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (06) : 2020 - 2028
  • [9] Inflammatory gradient in Barrett's oesophagus: implications for disease complications
    Fitzgerald, RC
    Abdalla, S
    Onwuegbusi, BA
    Sirieix, P
    Saeed, IT
    Burnham, WR
    Farthing, MJG
    [J]. GUT, 2002, 51 (03) : 316 - 322
  • [10] T cell proliferation is blocked by indoleamine 2,3-dioxygenase
    Frumento, G
    Rotondo, R
    Tonetti, M
    Ferrara, GB
    [J]. TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 428 - 430